Yubo International Biotech Ltd Cash Flow Statement
YBGJ|15 years of annual SEC 10-K data (FY2010-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Yubo International Biotech Ltd used $842,802 in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.1M | -$1.8M | -$1.2M | -$1.2M | -$1.5M | -$711.8K | -$148.0K | -$148.0K | -$144.0K | -$224.0K | -$130.0K | -$116.0K | -$106.0K | -$84.0K | -$110.0K |
| Depreciation & Amortization | $167.6K | $169.9K | $178.3K | $18.1K | $13.2K | $13.1K | - | - | - | - | - | - | - | - | - |
| Operating Cash Flow | -$842.8K | -$1.3M | -$739.0K | -$601.0K | -$1.0M | $101.1K | -$32.0K | -$55.0K | -$55.0K | -$55.0K | -$56.0K | -$63.0K | -$46.0K | -$43.0K | -$49.0K |
| Capital Expenditures | - | - | - | $0 | $564.7K | $42.6K | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | -$601.0K | -$1.6M | $58.6K | - | - | - | - | - | - | - | - | - |
| FCF Margin | - | - | - | -576.3% | -127.4% | - | - | - | - | - | - | - | - | - | - |